Ogata H - Search Results

1

Uptake of lamivudine by rat renal brush border membrane vesicles.

Takubo T, Kato T, Kinami J, Hanada K, Ogata H. Takubo T, et al. Among authors: ogata h. J Pharm Pharmacol. 2002 Jan;54(1):111-7. doi: 10.1211/0022357021771814. J Pharm Pharmacol. 2002. PMID: 11829121

2

Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.

Hanada K, Asano K, Nishimura T, Chimata T, Matsuo Y, Tsuchiya M, Ogata H. Hanada K, et al. Among authors: ogata h. J Pharm Pharmacol. 2008 Mar;60(3):317-22. doi: 10.1211/jpp.60.3.0006. J Pharm Pharmacol. 2008. PMID: 18284811

3

Pharmacokinetics and toxicodynamics of cisplatin and its metabolites in rats: relationship between renal handling and nephrotoxicity of cisplatin.

Hanada K, Ninomiya K, Ogata H. Hanada K, et al. Among authors: ogata h. J Pharm Pharmacol. 2000 Nov;52(11):1345-53. doi: 10.1211/0022357001777496. J Pharm Pharmacol. 2000. PMID: 11186242

4

Decomposition kinetics of cisplatin in human biological fluids.

Nagai N, Okuda R, Kinoshita M, Ogata H. Nagai N, et al. Among authors: ogata h. J Pharm Pharmacol. 1996 Sep;48(9):918-24. doi: 10.1111/j.2042-7158.1996.tb06002.x. J Pharm Pharmacol. 1996. PMID: 8910854

5

Pharmacokinetic and pharmacodynamic analysis of TS-943, a selective non-peptide platelet glycoprotein-IIb/IIIa (GPIIb/IIIa) receptor antagonist, using a nonlinear mixed effect model in dogs.

Furuya A, Nozawa M, Gotoh J, Jingu S, Akimoto M, Higuchi S, Suwa T, Ogata H. Furuya A, et al. Among authors: ogata h. J Pharm Pharmacol. 2002 Jul;54(7):921-7. doi: 10.1211/002235702760089036. J Pharm Pharmacol. 2002. PMID: 12162710

6

Effect of trimethoprim on the renal clearance of lamivudine in rats.

Takubo T, Kato T, Kinami J, Hanada K, Ogata H. Takubo T, et al. Among authors: ogata h. J Pharm Pharmacol. 2000 Mar;52(3):315-20. doi: 10.1211/0022357001774011. J Pharm Pharmacol. 2000. PMID: 10757420

7

Effect of lamivudine on uptake of organic cations by rat renal brush-border and basolateral membrane vesicles.

Takubo T, Kato T, Kinami J, Hanada K, Ogata H. Takubo T, et al. Among authors: ogata h. J Pharm Pharmacol. 2000 May;52(5):569-75. doi: 10.1211/0022357001774219. J Pharm Pharmacol. 2000. PMID: 10864146

8

Effect of buthionine sulphoximine, glutathione and methimazole on the renal disposition of cisplatin and on cisplatin-induced nephrotoxicity in rats: pharmacokinetic-toxicodynamic analysis.

Hanada K, Mukasa Y, Nomizo Y, Ogata H. Hanada K, et al. Among authors: ogata h. J Pharm Pharmacol. 2000 Dec;52(12):1483-90. doi: 10.1211/0022357001777694. J Pharm Pharmacol. 2000. PMID: 11197076

9

Compatibility of intravenous fat emulsions with prodrug amino acids.

Ishii F, Takamura A, Ogata H. Ishii F, et al. Among authors: ogata h. J Pharm Pharmacol. 1988 Feb;40(2):89-92. doi: 10.1111/j.2042-7158.1988.tb05187.x. J Pharm Pharmacol. 1988. PMID: 2897459

10

Effect of phospholipid emulsifiers on physicochemical properties of intravenous fat emulsions and/or drug carrier emulsions.

Ishii F, Sasaki I, Ogata H. Ishii F, et al. Among authors: ogata h. J Pharm Pharmacol. 1990 Jul;42(7):513-5. doi: 10.1111/j.2042-7158.1990.tb06609.x. J Pharm Pharmacol. 1990. PMID: 1980297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results